Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Evaluation of a conjugate vaccine platform against enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni and Shigella.

Laird RM, Ma Z, Dorabawila N, Pequegnat B, Omari E, Liu Y, Maue AC, Poole ST, Maciel M, Satish K, Gariepy CL, Schumack NM, McVeigh AL, Poly F, Ewing CP, Prouty MG, Monteiro MA, Savarino SJ, Guerry P.

Vaccine. 2018 Oct 29;36(45):6695-6702. doi: 10.1016/j.vaccine.2018.09.052. Epub 2018 Sep 27.

2.

The Structure and Phenology of Non-Native Scolytine Beetle Communities in Coffee Plantations on Kaua'i.

Bernard J, Ewing CP, Messing RH.

Insects. 2018 Sep 20;9(4). pii: E123. doi: 10.3390/insects9040123.

3.

Campylobacter jejuni transcriptional and genetic adaptation during human infection.

Crofts AA, Poly FM, Ewing CP, Kuroiwa JM, Rimmer JE, Harro C, Sack D, Talaat KR, Porter CK, Gutierrez RL, DeNearing B, Brubaker J, Laird RM, Maue AC, Jaep K, Alcala A, Tribble DR, Riddle MS, Ramakrishnan A, McCoy AJ, Davies BW, Guerry P, Trent MS.

Nat Microbiol. 2018 Apr;3(4):494-502. doi: 10.1038/s41564-018-0133-7. Epub 2018 Mar 27.

4.

The Native Hawaiian Insect Microbiome Initiative: A Critical Perspective for Hawaiian Insect Evolution.

Poff KE, Stever H, Reil JB, Seabourn P, Ching AJ, Aoki S, Logan M, Michalski JR, Santamaria J, Adams JW, Eiben JA, Yew JY, Ewing CP, Magnacca KN, Bennett GM.

Insects. 2017 Dec 19;8(4). pii: E130. doi: 10.3390/insects8040130.

5.

Phase-Variable Changes in the Position of O-Methyl Phosphoramidate Modifications on the Polysaccharide Capsule of Campylobacter jejuni Modulate Serum Resistance.

Pequegnat B, Laird RM, Ewing CP, Hill CL, Omari E, Poly F, Monteiro MA, Guerry P.

J Bacteriol. 2017 Jun 27;199(14). pii: e00027-17. doi: 10.1128/JB.00027-17. Print 2017 Jul 15.

6.

Synthesis and immunodetection of 6-O-methyl-phosphoramidyl-α-D-galactose: a Campylobacter jejuni antigenic determinant.

Jiao Y, Ma Z, Ewing CP, Guerry P, Monteiro MA.

Carbohydr Res. 2015 Dec 11;418:9-12. doi: 10.1016/j.carres.2015.09.012. Epub 2015 Oct 3.

PMID:
26513759
7.

The design of a capsule polysaccharide conjugate vaccine against Campylobacter jejuni serotype HS15.

Bertolo L, Ewing CP, Maue A, Poly F, Guerry P, Monteiro MA.

Carbohydr Res. 2013 Jan 25;366:45-9. doi: 10.1016/j.carres.2012.11.017. Epub 2012 Dec 2.

PMID:
23261782
8.

The polysaccharide capsule of Campylobacter jejuni modulates the host immune response.

Maue AC, Mohawk KL, Giles DK, Poly F, Ewing CP, Jiao Y, Lee G, Ma Z, Monteiro MA, Hill CL, Ferderber JS, Porter CK, Trent MS, Guerry P.

Infect Immun. 2013 Mar;81(3):665-72. doi: 10.1128/IAI.01008-12. Epub 2012 Dec 17.

9.

Functional characterization of flagellin glycosylation in Campylobacter jejuni 81-176.

Ewing CP, Andreishcheva E, Guerry P.

J Bacteriol. 2009 Nov;191(22):7086-93. doi: 10.1128/JB.00378-09. Epub 2009 Sep 11.

10.

Structure of a sigma28-regulated nonflagellar virulence protein from Campylobacter jejuni.

Yokoyama T, Paek S, Ewing CP, Guerry P, Yeo HJ.

J Mol Biol. 2008 Dec 12;384(2):364-76. doi: 10.1016/j.jmb.2008.09.036. Epub 2008 Sep 23.

11.

Divergence of quaternary structures among bacterial flagellar filaments.

Galkin VE, Yu X, Bielnicki J, Heuser J, Ewing CP, Guerry P, Egelman EH.

Science. 2008 Apr 18;320(5874):382-5. doi: 10.1126/science.1155307.

12.

Protein glycosylation in Campylobacter jejuni: partial suppression of pglF by mutation of pseC.

Guerry P, Ewing CP, Schoenhofen IC, Logan SM.

J Bacteriol. 2007 Sep;189(18):6731-3. Epub 2007 Jul 13.

13.

Targeted metabolomics analysis of Campylobacter coli VC167 reveals legionaminic acid derivatives as novel flagellar glycans.

McNally DJ, Aubry AJ, Hui JP, Khieu NH, Whitfield D, Ewing CP, Guerry P, Brisson JR, Logan SM, Soo EC.

J Biol Chem. 2007 May 11;282(19):14463-75. Epub 2007 Mar 19.

14.

Metschnikowia orientalis sp. nov., an Australasian yeast from nitidulid beetles.

Lachance MA, Bowles JM, Wiens F, Dobson J, Ewing CP.

Int J Syst Evol Microbiol. 2006 Oct;56(Pt 10):2489-93.

PMID:
17012584
15.

Changes in flagellin glycosylation affect Campylobacter autoagglutination and virulence.

Guerry P, Ewing CP, Schirm M, Lorenzo M, Kelly J, Pattarini D, Majam G, Thibault P, Logan S.

Mol Microbiol. 2006 Apr;60(2):299-311.

16.

A sigma28-regulated nonflagella gene contributes to virulence of Campylobacter jejuni 81-176.

Goon S, Ewing CP, Lorenzo M, Pattarini D, Majam G, Guerry P.

Infect Immun. 2006 Jan;74(1):769-72.

17.
18.

Pseudaminic acid, the major modification on Campylobacter flagellin, is synthesized via the Cj1293 gene.

Goon S, Kelly JF, Logan SM, Ewing CP, Guerry P.

Mol Microbiol. 2003 Oct;50(2):659-71.

19.

Structural heterogeneity of carbohydrate modifications affects serospecificity of Campylobacter flagellins.

Logan SM, Kelly JF, Thibault P, Ewing CP, Guerry P.

Mol Microbiol. 2002 Oct;46(2):587-97.

20.

DNA sequence and mutational analyses of the pVir plasmid of Campylobacter jejuni 81-176.

Bacon DJ, Alm RA, Hu L, Hickey TE, Ewing CP, Batchelor RA, Trust TJ, Guerry P.

Infect Immun. 2002 Nov;70(11):6242-50.

21.

Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro.

Guerry P, Szymanski CM, Prendergast MM, Hickey TE, Ewing CP, Pattarini DL, Moran AP.

Infect Immun. 2002 Feb;70(2):787-93.

22.

Identification of the carbohydrate moieties and glycosylation motifs in Campylobacter jejuni flagellin.

Thibault P, Logan SM, Kelly JF, Brisson JR, Ewing CP, Trust TJ, Guerry P.

J Biol Chem. 2001 Sep 14;276(37):34862-70. Epub 2001 Jul 18.

23.

Introduction to this issue: youth violence.

Ewing CP.

Behav Sci Law. 2001;19(1):1-2. No abstract available.

PMID:
11241677
24.

Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni.

Guerry P, Ewing CP, Hickey TE, Prendergast MM, Moran AP.

Infect Immun. 2000 Dec;68(12):6656-62.

25.

Involvement of a plasmid in virulence of Campylobacter jejuni 81-176.

Bacon DJ, Alm RA, Burr DH, Hu L, Kopecko DJ, Ewing CP, Trust TJ, Guerry P.

Infect Immun. 2000 Aug;68(8):4384-90.

26.

Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuni.

Lee LH, Burg E 3rd, Baqar S, Bourgeois AL, Burr DH, Ewing CP, Trust TJ, Guerry P.

Infect Immun. 1999 Nov;67(11):5799-805.

27.

Introduction to threat assessment

Ewing CP.

Behav Sci Law. 1999;17(3):251-2. No abstract available.

PMID:
10481127
28.

Evidence for a system of general protein glycosylation in Campylobacter jejuni.

Szymanski CM, Yao R, Ewing CP, Trust TJ, Guerry P.

Mol Microbiol. 1999 Jun;32(5):1022-30.

29.

Campylobacter jejuni-stimulated secretion of interleukin-8 by INT407 cells.

Hickey TE, Baqar S, Bourgeois AL, Ewing CP, Guerry P.

Infect Immun. 1999 Jan;67(1):88-93.

30.

The measurement of insanity: debating the merits of the R-CRAS and its alternatives.

Rogers R, Ewing CP.

Int J Law Psychiatry. 1992;15(1):113-23. No abstract available.

PMID:
1582740
31.

Increased population densities of Amblyomma americanum (Acari: Ixodidae) on Long Island, New York.

Ginsberg HS, Ewing CP, O'Connell AF Jr, Bosler EM, Daley JG, Sayre MW.

J Parasitol. 1991 Jun;77(3):493-5.

PMID:
2040963
33.
34.

Deer ticks, Ixodes dammini (Acari: Ixodidae), and Lyme disease spirochetes, Borrelia burgdorferi, in Maine.

Ginsberg HS, Ewing CP.

J Med Entomol. 1988 Jul;25(4):303-4. No abstract available.

PMID:
3404548
35.

The use of law for prevention in the public interest.

Levine M, Ewing CP, Levine DI.

Prev Hum Serv. 1987 Spring-Summer;5(2):241-77.

PMID:
10285530
36.

Juvenile and family mental health law in sociohistorical context.

Levine M, Ewing CP, Hager R.

Int J Law Psychiatry. 1987;10(2):91-109. No abstract available.

PMID:
3316072

Supplemental Content

Loading ...
Support Center